Type 1 diabetes intervention trials: What have we learned? A critical review of selected intervention trialsGREENBAUM, Carla J.Clinical immunology (Orlando, Fla. Print). 2002, Vol 104, Num 2, pp 97-104, issn 1521-6616, 8 p.Article

Insulin resistance in type 1 diabetesGREENBAUM, Carla J.Diabetes/metabolism research and reviews (Print). 2002, Vol 18, Num 3, pp 192-200, issn 1520-7552Article

Low serum conditions for in vitro generation of human macrophages with macrophage colony stimulating factorPLESNER, Annette; GREENBAUM, Carla J; LERNMARK, Ake et al.Journal of immunological methods. 2001, Vol 249, Num 1-2, pp 53-61, issn 0022-1759Article

Guidelines for intervention trials in subjects with newly diagnosed type 1 diabetesGREENBAUM, Carla J; HARRISON, Leonard C.Diabetes (New York, NY). 2003, Vol 52, Num 5, pp 1059-1065, issn 0012-1797, 7 p.Article

Type 1 Diabetes manifested solely by 2-h oral glucose tolerance test criteriaGREENBAUM, Carla J; CUTHBERTSON, David; KRISCHER, Jeffrey P et al.Diabetes (New York, NY). 2001, Vol 50, Num 2, pp 470-476, issn 0012-1797Article

ICA+ relatives with DQA1*0102/DQB1*0602 have expected 0602 sequence and DR typesGREENBAUM, Carla J; GAUR, Lakshmi K; NOBLE, Janelle A et al.Journal of autoimmunity (Print). 2002, Vol 18, Num 1, pp 67-70, issn 0896-8411Article

Use of oral glucose minimal model-derived index of insulin sensitivity in subjects with early type 1 diabetes mellitusKRUDYS, Kevin M; GREENBAUM, Carla J; PIHOKER, Catherine et al.Metabolism, clinical and experimental. 2008, Vol 57, Num 4, pp 445-447, issn 0026-0495, 3 p.Article

Impaired β-cell function, incretin effect, and glucagon suppression in patients with type 1 diabetes who have normal fasting glucoseGREENBAUM, Carla J; PRIGEON, Ronald L; D'ALESSIO, David A et al.Diabetes (New York, NY). 2002, Vol 51, Num 4, pp 951-957, issn 0012-1797Article

Through the Fog: Recent Clinical Trials to Preserve β-Cell Function in Type 1 DiabetesGREENBAUM, Carla J; SCHATZ, Desmond A; HALLER, Michael J et al.Diabetes (New York, NY). 2012, Vol 61, Num 6, pp 1323-1330, issn 0012-1797, 8 p.Article

Autoimmunity to islet proteins in children diagnosed with new-onset diabetesBROOKS-WORRELL, Barbara M; GREENBAUM, Carla J; PALMER, Jerry P et al.The Journal of clinical endocrinology and metabolism. 2004, Vol 89, Num 5, pp 2222-2227, issn 0021-972X, 6 p.Article

Low HERV-K(C4) Copy Number Is Associated With Type 1 DiabetesMASON, Mike J; SPEAKE, Cate; GERSUK, Vivian H et al.Diabetes (New York, NY). 2014, Vol 63, Num 5, pp 1789-1795, issn 0012-1797, 7 p.Article

Rapamycin/IL-2 Combination Therapy in Patients With Type 1 Diabetes Augments Tregs yet Transiently Impairs β-Cell FunctionLONG, S. Alice; RIECK, Mary; TURKA, Laurence A et al.Diabetes (New York, NY). 2012, Vol 61, Num 9, pp 2340-2348, issn 0012-1797, 9 p.Article

Co-stimulation modulation with abatacept in patients with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled trialORBAN, Tihamer; BUNDY, Brian; MORAN, Antoinette et al.Lancet (British edition). 2011, Vol 378, Num 9789, pp 412-419, issn 0140-6736, 8 p.Article

Zinc Transporter-8 Autoantibodies Improve Prediction of Type 1 Diabetes in Relatives Positive for the Standard Biochemical AutoantibodiesLIPING YU; BOULWARE, David C; EISENBARTH, George S et al.Diabetes care. 2012, Vol 35, Num 6, pp 1213-1218, issn 0149-5992, 6 p.Article

Patterns of metabolic progression to type 1 diabetes in the diabetes prevention trial-type 1SOSENKO, Jay M; PALMER, Jerry P; CUTHBERTSON, David et al.Diabetes care. 2006, Vol 29, Num 3, pp 643-649, issn 0149-5992, 7 p.Article

Autoimmunity and clinical course in children with type 1, type 2, and type 1.5 diabetesGILLIAM, Lisa K; BROOKS-WORRELL, Barbara M; PALMER, Jerry P et al.Journal of autoimmunity (Print). 2005, Vol 25, Num 3, pp 244-250, issn 0896-8411, 7 p.Conference Paper

Islet cell antibodies and glutamic acid decarboxylase antibodies, but not the clinical phenotype, help to identify type 11/2 diabetes in patients presenting with type 2 diabetesJUNEJA, Rattan; HIRSCH, Irl B; NAIK, Ramachandra G et al.Metabolism, clinical and experimental. 2001, Vol 50, Num 9, pp 1008-1013, issn 0026-0495Article

B-Lymphocyte Depletion With Rituximab and β-Cell Function: Two-Year ResultsPESCOVITZ, Mark D; GREENBAUM, Carla J; RODRIGUEZ, Henry et al.Diabetes care. 2014, Vol 37, Num 2, pp 453-459, issn 0149-5992, 7 p.Article

Use of the Diabetes Prevention Trial-Type 1 Risk Score (DPTRS) for Improving the Accuracy of the Risk Classification of Type 1 DiabetesSOSENKO, Jay M; SKYLER, Jay S; HEROLD, Kevan C et al.Diabetes care. 2014, Vol 37, Num 4, pp 979-984, issn 0149-5992, 6 p.Article

Teplizumab (Anti-CD3 mAb) Treatment Preserves C-Peptide Responses in Patients With New-Onset Type 1 Diabetes in a Randomized Controlled Trial: Metabolic and Immunologic Features at Baseline Identify a Subgroup of RespondersHEROLD, Kevan C; GITELMAN, Stephen E; SAYRE, Peter H et al.Diabetes (New York, NY). 2013, Vol 62, Num 11, pp 3766-3774, issn 0012-1797, 9 p.Article

The Application of the Diabetes Prevention Trial-Type 1 Risk Score for Identifying a Preclinical State of Type 1 DiabetesSOSENKO, Jay M; SKYLER, Jay S; PALMER, Jerry P et al.Diabetes care. 2012, Vol 35, Num 7, pp 1552-1555, issn 0149-5992, 4 p.Article

Preservation of 3-Cell Function in Autoantibody-Positive Youth With DiabetesGREENBAUM, Carla J; ANDERSON, Andrea M; DOLAN, Lawrence M et al.Diabetes care. 2009, Vol 32, Num 10, pp 1839-1844, issn 0149-5992, 6 p.Article

Standardization of C-Peptide MeasurementsLITTLE, Randie R; ROHLFING, Curt L; TENNILL, Alethea L et al.Clinical chemistry (Baltimore, Md.). 2008, Vol 54, Num 6, pp 1023-1026, issn 0009-9147, 4 p.Article

Acceleration of the Loss of the First-Phase Insulin Response During the Progression to Type 1 Diabetes in Diabetes Prevention Trial―Type 1 ParticipantsSOSENKO, Jay M; SKYLER, Jay S; BEAM, Craig A et al.Diabetes (New York, NY). 2013, Vol 62, Num 12, pp 4179-4183, issn 0012-1797, 5 p.Article

Glucose Excursions Between States of Glycemia With Progression to Type 1 Diabetes in the Diabetes Prevention Trial-Type 1 (DPT-1)SOSENKO, Jay M; SKYLER, Jay S; PALMER, Jerry P et al.Diabetes (New York, NY). 2010, Vol 59, Num 10, pp 2386-2389, issn 0012-1797, 4 p.Article